MAPK3 and neoplasm: We observed a 40% reduction in Shp1 protein levels in peripheral blood cells from tumor-bearing Ptpn6fl/fl ERT2-Cre mice following tamoxifen treatment (Figure 4F), and mice began to show bodyweight loss consistent with development of the motheaten phenotype (Supplementary Figure 5D).